N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide

C141H212N50O9+8 — CID 158852524

IUPACN-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide
SMILESCC(=O)Nc1ccc(N(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCCOC(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCN(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCCCCCCCNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNCCN(C)c1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C
InChIInChI=1S/C21H32N6O.C19H28N6O2.2C19H28N6O.2C17H25N7O.C15H20N6O.C14H18N6O/c1-5-6-7-8-9-10-13-22-19-12-11-18(23-17(2)28)16-20(19)24-25-21-26(3)14-15-27(21)4;1-14(2)27-12-6-9-20-17-8-7-16(21-15(3)26)13-18(17)22-23-19-24(4)10-11-25(19)5;2*1-7-19(3,4)13-20-16-9-8-15(21-14(2)26)12-17(16)22-23-18-24(5)10-11-25(18)6;1-13(25)19-14-6-7-16(22(3)9-8-18-2)15(12-14)20-21-17-23(4)10-11-24(17)5;1-13(25)19-14-6-7-15(18-8-9-22(2)3)16(12-14)20-21-17-23(4)10-11-24(17)5;1-11(22)16-12-6-7-14(19(2)3)13(10-12)17-18-15-20(4)8-9-21(15)5;1-10(21)16-11-5-6-12(15-2)13(9-11)17-18-14-19(3)7-8-20(14)4/h11-12,14-16H,5-10,13H2,1-4H3,(H,23,24,28);7-8,10-11,13-14H,6,9,12H2,1-5H3,(H,21,22,26);2*8-12H,7,13H2,1-6H3,(H,21,22,26);6-7,10-12,18H,8-9H2,1-5H3;6-7,10-12H,8-9H2,1-5H3,(H,19,20,25);6-10H,1-5H3;5-9H,1-4H3,(H,16,17,21)/p+8
InChIKeyIZQIMASSHJJEKJ-UHFFFAOYSA-V
MW2751.59 g/mol
LogP25.22
Rot. Bonds56

About N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide

N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide (PubChem CID 158852524) has the molecular formula C141H212N50O9+8 and a molecular weight of 2751.59 g/mol. Its IUPAC name is N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide.

Molecular Properties

Compound NameN-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide
PubChem CID158852524
Molecular FormulaC141H212N50O9+8
Molecular Weight2751.59 g/mol
Exact Mass2749.76
IUPAC NameN-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide
SMILESCC(=O)Nc1ccc(N(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCCOC(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCN(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCCCCCCCNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNCCN(C)c1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C
InChIInChI=1S/C21H32N6O.C19H28N6O2.2C19H28N6O.2C17H25N7O.C15H20N6O.C14H18N6O/c1-5-6-7-8-9-10-13-22-19-12-11-18(23-17(2)28)16-20(19)24-25-21-26(3)14-15-27(21)4;1-14(2)27-12-6-9-20-17-8-7-16(21-15(3)26)13-18(17)22-23-19-24(4)10-11-25(19)5;2*1-7-19(3,4)13-20-16-9-8-15(21-14(2)26)12-17(16)22-23-18-24(5)10-11-25(18)6;1-13(25)19-14-6-7-16(22(3)9-8-18-2)15(12-14)20-21-17-23(4)10-11-24(17)5;1-13(25)19-14-6-7-15(18-8-9-22(2)3)16(12-14)20-21-17-23(4)10-11-24(17)5;1-11(22)16-12-6-7-14(19(2)3)13(10-12)17-18-15-20(4)8-9-21(15)5;1-10(21)16-11-5-6-12(15-2)13(9-11)17-18-14-19(3)7-8-20(14)4/h11-12,14-16H,5-10,13H2,1-4H3,(H,23,24,28);7-8,10-11,13-14H,6,9,12H2,1-5H3,(H,21,22,26);2*8-12H,7,13H2,1-6H3,(H,21,22,26);6-7,10-12,18H,8-9H2,1-5H3;6-7,10-12H,8-9H2,1-5H3,(H,19,20,25);6-10H,1-5H3;5-9H,1-4H3,(H,16,17,21)/p+8
InChIKeyIZQIMASSHJJEKJ-UHFFFAOYSA-V
XLogP25.22
TPSA604.20 Ų
H-Bond Donors15
H-Bond Acceptors43
Rotatable Bonds56
Heavy Atoms200
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002751.59
LogP ≤ 525.22
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide?
The IUPAC name of N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide (CID 158852524) is N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide.
What is the SMILES notation for N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide?
The canonical SMILES for N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide is CC(=O)Nc1ccc(N(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCCOC(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CC(=O)Nc1ccc(NCCN(C)C)c(/N=N/c2n(C)cc[n+]2C)c1.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCC(C)(C)CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CCCCCCCCNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNCCN(C)c1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.CNc1ccc(NC(C)=O)cc1/N=N/c1n(C)cc[n+]1C.
What is the InChIKey of N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide?
The InChIKey is IZQIMASSHJJEKJ-UHFFFAOYSA-V. The full InChI is InChI=1S/C21H32N6O.C19H28N6O2.2C19H28N6O.2C17H25N7O.C15H20N6O.C14H18N6O/c1-5-6-7-8-9-10-13-22-19-12-11-18(23-17(2)28)16-20(19)24-25-21-26(3)14-15-27(21)4;1-14(2)27-12-6-9-20-17-8-7-16(21-15(3)26)13-18(17)22-23-19-24(4)10-11-25(19)5;2*1-7-19(3,4)13-20-16-9-8-15(21-14(2)26)12-17(16)22-23-18-24(5)10-11-25(18)6;1-13(25)19-14-6-7-16(22(3)9-8-18-2)15(12-14)20-21-17-23(4)10-11-24(17)5;1-13(25)19-14-6-7-15(18-8-9-22(2)3)16(12-14)20-21-17-23(4)10-11-24(17)5;1-11(22)16-12-6-7-14(19(2)3)13(10-12)17-18-15-20(4)8-9-21(15)5;1-10(21)16-11-5-6-12(15-2)13(9-11)17-18-14-19(3)7-8-20(14)4/h11-12,14-16H,5-10,13H2,1-4H3,(H,23,24,28);7-8,10-11,13-14H,6,9,12H2,1-5H3,(H,21,22,26);2*8-12H,7,13H2,1-6H3,(H,21,22,26);6-7,10-12,18H,8-9H2,1-5H3;6-7,10-12H,8-9H2,1-5H3,(H,19,20,25);6-10H,1-5H3;5-9H,1-4H3,(H,16,17,21)/p+8.
What are the key properties of N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide?
N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide has a molecular weight of 2751.59 g/mol, XLogP of 25.22, 56 rotatable bonds, 15 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(dimethylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;N-[4-[2-(dimethylamino)ethylamino]-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide;bis(N-[4-(2,2-dimethylbutylamino)-3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]phenyl]acetamide);N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(methylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-[methyl-[2-(methylamino)ethyl]amino]phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(octylamino)phenyl]acetamide;N-[3-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-4-(3-propan-2-yloxypropylamino)phenyl]acetamide is sourced from PubChem (CID 158852524), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).